• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy and Safety of D-dimer, Weight, and Renal Function-Adjusted Thromboprophylaxis in Patients with Coronavirus Disease 2019 (COVID-19).

作者信息

Arachchillage Deepa R J, Shi Christine, Saliu David, Kozman Peter, Mi Emma, Buti Noora, Kashef Elika, Copley Susan J, Gomez Carlos, Leonard Richard, Aziz Riaz, Shlebak Abdul A, Laffan Mike

机构信息

Department of Haematology, Imperial College Healthcare NHS Trust, London, United Kingdom.

Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.

出版信息

Semin Thromb Hemost. 2021 Jun;47(4):436-441. doi: 10.1055/s-0040-1722309. Epub 2021 Jan 22.

DOI:10.1055/s-0040-1722309
PMID:33482676
Abstract
摘要

相似文献

1
Efficacy and Safety of D-dimer, Weight, and Renal Function-Adjusted Thromboprophylaxis in Patients with Coronavirus Disease 2019 (COVID-19).D-二聚体、体重及肾功能调整的血栓预防措施在2019冠状病毒病（COVID-19）患者中的疗效与安全性
Semin Thromb Hemost. 2021 Jun;47(4):436-441. doi: 10.1055/s-0040-1722309. Epub 2021 Jan 22.
2
Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.2019冠状病毒病、血栓形成前因素与静脉血栓栓塞症
Semin Thromb Hemost. 2020 Oct;46(7):772-776. doi: 10.1055/s-0040-1710337. Epub 2020 May 11.
3
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II.2019冠状病毒病（COVID-19）中的止血维持与血栓形成预防：第二部分。
Semin Thromb Hemost. 2021 Jun;47(4):333-337. doi: 10.1055/s-0041-1728775. Epub 2021 Jun 1.
4
Thromboelastography-Guided Management of Anticoagulated COVID-19 Patients to Prevent Hemorrhage.血栓弹力图引导下抗凝 COVID-19 患者的管理以预防出血
Semin Thromb Hemost. 2021 Jun;47(4):442-446. doi: 10.1055/s-0041-1723754. Epub 2021 Feb 19.
5
Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study.重症新型冠状病毒肺炎患者止血的血栓前状态紊乱：一项前瞻性纵向观察研究。
Thromb Res. 2021 Jan;197:20-23. doi: 10.1016/j.thromres.2020.10.025. Epub 2020 Oct 24.
6
Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays.新型冠状病毒病凝血功能障碍的评估；应用血栓生成和非传统止血检测进行实验室特征描述。
Int J Lab Hematol. 2021 Feb;43(1):123-130. doi: 10.1111/ijlh.13329. Epub 2020 Sep 5.
7
Enoxaparin Effect on Interleukin-10 Levels in Iraqi Patients with COVID-19: A Case-Control Study.依诺肝素对伊拉克新冠肺炎患者白细胞介素-10水平的影响：一项病例对照研究。
Front Biosci (Schol Ed). 2024 Apr 30;16(2):9. doi: 10.31083/j.fbs1602009.
8
D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study.COVID-19 住院时的 D-二聚体与住院死亡率相关，与静脉血栓栓塞无关：来自法国多中心队列研究的见解。
Arch Cardiovasc Dis. 2021 May;114(5):381-393. doi: 10.1016/j.acvd.2021.02.003. Epub 2021 Mar 9.
9
Effect of Enoxaparin on D-dimer levels in hospitalized Corona Virus patients with a comparison of its level in patients with comorbid conditions.依诺肝素对合并症冠状病毒住院患者 D-二聚体水平的影响及其与患者合并症的比较。
Wiad Lek. 2024;77(4):828-833. doi: 10.36740/WLek202404131.
10
Fatal Disseminated Intravascular Coagulopathy in Covid-19: A Small Case Series.新型冠状病毒肺炎相关的致死性弥散性血管内凝血：一项小型病例系列研究
Semin Thromb Hemost. 2021 Jun;47(4):427-430. doi: 10.1055/s-0040-1716871. Epub 2020 Dec 17.

引用本文的文献

1
Exploring heterogeneity in reported venous thromboembolism risk in COVID-19 and comparison to other viral pneumonias: a systematic review and meta-regression.探索COVID-19报告的静脉血栓栓塞风险的异质性并与其他病毒性肺炎进行比较：一项系统综述和Meta回归分析
Res Pract Thromb Haemost. 2023 Jul 13;7(5):102146. doi: 10.1016/j.rpth.2023.102146. eCollection 2023 Jul.
2
Incidence and outcomes of splanchnic vein thrombosis after diagnosis of COVID-19 or COVID-19 vaccination: a systematic review and meta-analysis.COVID-19 诊断后或 COVID-19 疫苗接种后肠系膜静脉血栓形成的发生率和结局：系统评价和荟萃分析。
J Thromb Thrombolysis. 2023 Jan;55(1):18-31. doi: 10.1007/s11239-022-02732-3. Epub 2022 Nov 19.
3
Thromboprophylaxis in COVID-19 - Rationale and considerations.
COVID-19 相关的血栓预防——基本原理和注意事项。
Adv Biol Regul. 2021 Aug;81:100819. doi: 10.1016/j.jbior.2021.100819. Epub 2021 Jul 23.
4
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP).成人新型冠状病毒肺炎患者在非重症监护病房的临床管理：来自意大利抗感染治疗学会（SITA）和意大利肺病学会（SIP）的指南
Infect Dis Ther. 2021 Dec;10(4):1837-1885. doi: 10.1007/s40121-021-00487-7. Epub 2021 Jul 30.
5
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.新冠病毒病是一种系统性血管血液病：对发病机制及临床方面的见解
Angiogenesis. 2021 Nov;24(4):755-788. doi: 10.1007/s10456-021-09805-6. Epub 2021 Jun 28.
6
Debate: Should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID-19 while we are awaiting the results of clinical trials?辩论：在等待临床试验结果期间，新冠病毒病患者预防静脉血栓形成的抗凝剂剂量或疗程是否应增加？
Br J Haematol. 2021 Feb;192(3):459-466. doi: 10.1111/bjh.17241. Epub 2020 Nov 25.